- Aphria on Thursday said it had named a committee to review its acquisition of the medical-cannabis company LATAM Holdings.
- On Monday, a short-seller put out a report saying the acquisition was largely worthless and accusing Aphria of being a “shell game with a cannabis business on the side.”
- Shares fell 12% early Thursday, taking them down by 40% since the short-seller’s report was released.
- Watch Aphria trade live.
Aphria fell further Thursday morning, down more than 12%, after the company said it…